Why is Par Drugs & Che. falling/rising?

As of 24-Sep, Par Drugs & Chemicals Ltd is experiencing a price increase, currently at 110.95, reflecting a change of 1.88 or 1.72% upward. The stock has shown mixed performance over various time frames; it has decreased by 4.85% over the past week but increased by 12.38% over the last month. Today's price summary indicates that the stock is outperforming its sector by 2.21% and is trading above its 20-day, 50-day, and 100-day moving averages, although it is below its 5-day and 200-day moving averages. The company has a low debt-to-equity ratio and a favorable return on equity of 14.3, suggesting an attractive valuation relative to its peers, despite a significant decline of 53.05% over the past year.
In the broader market context, while the stock has underperformed the market significantly over the past year, it has shown resilience in the short term compared to the benchmark, which has only declined by 1.08% over the past week. The company has faced challenges, including negative results for the last three consecutive quarters and a decline in profits. However, the recent price increase may be attributed to its attractive valuation metrics and improved performance relative to its sector, despite the long-term growth concerns and a substantial drop in net sales and operating profit over the last five years.